Univiv


Univiv is dedicated to developing safe and effective technologies across human, animal, and environmental sectors, focusing on antibiotic resistance, viral pandemic prevention, and ecosystem health. Founded in 2018, the company aims to address urgent global issues through innovative solutions rooted in the One Health philosophy.

Industries

biotechnology

Nr. of Employees

small (1-50)

Univiv

Unit 1, Site 6 Oaktree Business Park, Trim, Co.Meath, Ireland, C15 KH72


Products

Antiviral formulations for human and animal use

Formulated antiviral compositions intended for prevention and treatment of viral infections in humans and animals; includes approaches to deliver antigens and micronutrients orally.

Microbiome enhancement using archaeal consortia

Microbiome modulation products based on archaeal and other microbial strains to increase diversity and total population of beneficial microbes in gut, soil and water.

Microbial wastewater treatment and nutrient recovery

Biological wastewater treatment processes combining microbial consortia and micronutrients to improve biodegradation in anoxic conditions and recover nitrogen and phosphorus from waste streams.

Expertise Areas

  • Antiviral formulation development
  • Oral drug delivery and bioavailability enhancement
  • Microbiome modulation (archaea-based)
  • Natural product-derived antimicrobials
  • Show More (3)

Key Technologies

  • Formulation science for oral delivery
  • Oral bioavailability enhancement methods
  • Archaeal and microbial consortia for microbiome modulation
  • Natural product extraction and fractionation
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.